Search Results - Santosgallego, Carlos G

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Abstract 15407: Benefits of the Sglt2 Inhibitor Empagliflozin on Epicardial Adipose Tissue in Non-Diabetic Hfref

    Abstract 15407: Benefits of the Sglt2 Inhibitor Empagliflozin on Epicardial Adipose Tissue in Non-Diabetic Hfref by Santosgallego, Carlos G, Requena-Ibanez, Juan Antonio, Picatoste Botija, Maria Belen, Ishikawa, Kiyotake, Sanz, Javier, Fuster, Valentin, Badimon, Juan J

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 19069: Empagliflozin Improves Right Ventricular Remodeling and Right Ventricular Systolic Function in Non-Diabetic Hfref: Insights From Porcine and Human Studies

    Abstract 19069: Empagliflozin Improves Right Ventricular Remodeling and Right Ventricular Systolic Function in Non-Diabetic Hfref: Insights From Porcine and Human Studies by Santosgallego, Carlos G, Requena-Ibanez, Juan Antonio, Vargas Delgado, Ariana Patricia, Ishikawa, Kiyotake, Sanz, Javier, Lala, Anuradha, Contreras, Johanna P, Mancini, Donna M, Pinney, Sean, Bhatt, Deepak, Fuster, Valentin, Badimon, Juan J

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract 17157: The SGLT2 Inhibitor Empagliflozin Ameliorates Interstitial Myocardial Fibrosis and Aortic Stiffness in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial

    Abstract 17157: The SGLT2 Inhibitor Empagliflozin Ameliorates Interstitial Myocardial Fibrosis and Aortic Stiffness in Non-Diabetic Patients With Heart Failure With Reduced Ejectio... by Santosgallego, Carlos G, Requena-Ibanez, Juan Antonio, Vargas, Ariana P, Garcia-Ropero, Alvaro, Rodriguez-Cordero, Anderly, MANCINI, Donna M, Pinney, Sean, Lala, Anuradha, Contreras, Johanna P, Moreno, Pedro R, SANZ, Javier, Fuster, Valentin, Badimon, Juan J

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 17275: The SGLT2 Inhibitor Empagliflozin Ameliorates Left Atrial Dilatation in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial

    Abstract 17275: The SGLT2 Inhibitor Empagliflozin Ameliorates Left Atrial Dilatation in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysi... by Santosgallego, Carlos G, Requena-Ibanez, Juan Antonio, Vargas, Ariana, Garcia-Ropero, Alvaro, Rodriguez-Cordero, Anderly, Pinney, Sean, MANCINI, Donna M, Lala, Anuradha, Contreras, Johanna P, Moreno, Pedro R, SANZ, Javier, Fuster, Valentin, Badimon, Juan J

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 17367: Infusion of the Ketone Body β-Hydroxybutyrate Improves Left Ventricular Systolic Function in an Animal Model of Heart Failure With Reduced Ejection Fraction

    Abstract 17367: Infusion of the Ketone Body β-Hydroxybutyrate Improves Left Ventricular Systolic Function in an Animal Model of Heart Failure With Reduced Ejection Fraction by SantosGallego, Carlos G, Requena-Ibanez, Juan Antonio, San Antonio, Rodolfo, Ishikawa, Kiyotake, Picatoste, Belén, Garcia-Ropero, Alvaro, Sanz, Javier, Hajjar, Roger, Fuster, Valentin, Badimon, Juan J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 16270: Feature-Tracking Strain From Cardiac MRI Mapping Assesses Diagnosis, Severity, and Prognosis in Myocarditis

    Abstract 16270: Feature-Tracking Strain From Cardiac MRI Mapping Assesses Diagnosis, Severity, and Prognosis in Myocarditis by Garcia-Ropero, Alvaro J, SantosGallego, Carlos G, Agarwal, Chirag J, Weiss, Allen, Smoller, Rebecca, Fuster, Valentin, Badimon, Juan J, Sanz, Javier

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: